UK 23:15 Wednesday, 30 September 2026
Breaking news and expert analysis on fast-moving AIM and LSE listed shares
Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
I do not believe that Advanced Oncotherapy (AVO) will ever generate a cent of positive free cashflow as the demand for the proton therapy services it will offer at some point in 2023 is, in my view, already fully catered for with existing capacity. Others, notably a fund management firm run by a chap who looks remarkably like Daddy Pig, father of Peppa, disagree but what we might agree on its that, until late 2023, there is no doubt that Advanced will continue to guzzle cash. Which makes the next bailout placing only a matter of time.
Already a member? Sign in
• All premium articles
• Tom Winnifrith’s Bearcast
• Access to all the entire nearly 13 year archive
• ShareProphets Daily Newsletter
Cancel any time
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
